Recce’s unapproved drug proves successful treatment for life-threatening illness
Apr 2021 - Superbug and viral pathogen treatment developer Recce Pharmacetical (ASX:RCE)’s unapproved drug R327 has successfully saved a patient suffering a life-threatening illness.